Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis

Hepatic fibrosis can result as a pathological response to nonalcoholic steatohepatitis (NASH). Cirrhosis, the late stage of fibrosis, has been linked to poor survival and an increased risk of developing hepatocellular carcinoma, with limited treatment options available. Therefore, there is an unmet...

Descripción completa

Detalles Bibliográficos
Autores principales: Simón Serrano, Sonia, Grönberg, Alvar, Longato, Lisa, Rombouts, Krista, Kuo, Joseph, Gregory, Matthew, Moss, Steven, Elmér, Eskil, Mazza, Giuseppe, Gallay, Philippe, Pinzani, Massimo, Hansson, Magnus J., Massoumi, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912624/
https://www.ncbi.nlm.nih.gov/pubmed/31717385
http://dx.doi.org/10.3390/cells8111409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912624/
https://www.ncbi.nlm.nih.gov/pubmed/31717385
http://dx.doi.org/10.3390/cells8111409

Ejemplares similares